Re-purposed antiviral drugs without a purpose in COVID-19: a valuable lesson for clinicians

Eur Heart J. 2021 Mar 1;42(9):882-883. doi: 10.1093/eurheartj/ehab043.
No abstract available

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use*
  • COVID-19 / epidemiology
  • COVID-19 Drug Treatment*
  • Drug Repositioning / methods*
  • Humans
  • Pandemics*
  • SARS-CoV-2*

Substances

  • Antiviral Agents